liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Antibiotic consumption and antibiotic stewardship in Swedish hospitals
Linköping University, Department of Clinical and Experimental Medicine, Division of Microbiology and Molecular Medicine. Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Heart and Medicine Center, Department of Infectious Diseases.
Public Health Agency Sweden, Sweden .
Public Health Agency Sweden, Sweden Karolinska Institute, Sweden .
Karolinska University Hospital, Sweden .
2014 (English)In: Upsala Journal of Medical Sciences, ISSN 0300-9734, E-ISSN 2000-1967, Vol. 119, no 2, 154-161 p.Article, review/survey (Refereed) Published
Abstract [en]

Background. The aim of this paper was to describe and analyze the effect of antibiotic policy changes on antibiotic consumption in Swedish hospitals and to review antibiotic stewardship in Swedish hospitals. Results. The main findings were: 1) Antibiotic consumption has significantly increased in Swedish hospitals over the last decade. The consumption of cephalosporins has decreased, whereas that of most other drugs including piperacillin-tazobactam, carbapenems, and penicillinase-sensitive and -resistant penicillins has increased and replaced cephalosporins. 2) Invasive infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae have increased, but the proportion of pathogens resistant to third-generation cephalosporins causing invasive infections is still very low in a European and international perspective. Furthermore, the following gaps in knowledge were identified: 1) lack of national, regional, and local data on the incidence of antibiotic resistance among bacteria causing hospital-acquired infections e. g. bloodstream infections and hospital-acquired pneumonia-data on which standard treatment guidelines should be based; 2) lack of data on the incidence of Clostridium difficile infections and the effect of change of antibiotic policies on the incidence of C. difficile infections and infections caused by antibiotic-resistant pathogens; and 3) lack of prospective surveillance programs regarding appropriate antibiotic treatment, including selection of optimal antimicrobial drug regimens, dosage, duration of therapy, and adverse ecological effects such as increases in C. difficile infections and emergence of antibiotic-resistant pathogens. Conclusions. Evidence-based actions to improve antibiotic use and to slow down the problem of antibiotic resistance need to be strengthened. The effect of such actions should be analyzed, and standard treatment guidelines should be continuously updated at national, regional, and local levels.

Place, publisher, year, edition, pages
Informa Healthcare / Upsala Medical Society , 2014. Vol. 119, no 2, 154-161 p.
Keyword [en]
Antibiotic consumption; antibiotic resistance; antibiotic treatment guidelines
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-108178DOI: 10.3109/03009734.2014.909911ISI: 000336526100014OAI: diva2:729547
Available from: 2014-06-26 Created: 2014-06-26 Last updated: 2014-06-26

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Hanberger, Håkan
By organisation
Division of Microbiology and Molecular MedicineFaculty of Health SciencesDepartment of Infectious Diseases
In the same journal
Upsala Journal of Medical Sciences
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 206 hits
ReferencesLink to record
Permanent link

Direct link